Inamed is an international contract research organization (CRO) providing its clients with the full range of services, required for the planning, conduct and evaluation of clinical trials from phase I through phase IV, for nearly two decades.
During this time Inamed's clinical unit team gained solid experience in conducting early phase clinical trials in various indications, ranging from first-in-man studies up to highly complex clinical settings. Our in-house clinical pharmacology unit with 24 beds (+6 intensive monitoring beds), provides state-of-the-art clinic rooms and labs, which can be quickly adjusted to the study requirements in close coordination with our sponsors.
Our studies deliver the highest quality data and can enhance your clinical trials and development projects for drugs and medical devices, in order to enable sponsors to take the first steps to get their products to market successfully.Read more
Beside the respiratory expertise, the company INAMED is known for the planning and conduct of dedicated safety trials (e.g., First in Man [FIM] or cardiac safety trials), pharmacokinetic and pharmacodynamic trials in healthy subjects or patients, and clinical studies with complex endpoints such as Proof-of-Concept (PoC) trials. At our facilities in Munich-Gauting, highly-controlled clinical studies in early clinical development are conducted by a qualified team of several physicians and study nurses under the direction of a board-accredited clinical pharmacologist.Read more